Concepedia

Bradley K. Evans

BK

Statistics

Publications

10

Citations

292

H-Index

10

Active since

1983

Affiliations

Research Triangle Park Foundation(Current)

Birmingham VA Medical Center

GlaxoSmithKline (United States)

Baylor College of Medicine

Bradley K. Evans is an author at Research Triangle Park Foundation specializing in neurology, pharmacotherapy, and medicine.

Publications per year

1983–2022

10

Publications

10

Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy

David Honeycutt, Karen Callahan, Lane Rutledge et al. · Neurology · 1992 · 75 citations

Life Sciences, Molecular Genetics, Pharmacotherapy +15

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients

Gavin Giovannoni, Jeffrey Cohen, Alasdair Coles et al. · Neurology · 2016 · 62 citations · Full text

Medicine, Neurology, Pharmacotherapy +13

HTLV‐I‐associated myelopathy and polymyositis in a US native

Bradley K. Evans, Ira Gore, L. E. Harrell et al. · Neurology · 1989 · 48 citations

Life Sciences, Infectious Diseases, Neurology +16

Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies

Olivier Rascol, Lars Tönges, Tina deVries et al. · Parkinsonism & Related Disorders · 2022 · 21 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

The “Schaltenbrand experiment,” Wurzburg, 1940

Michael Shevell, Bradley K. Evans · Neurology · 1994 · 20 citations

Life Sciences, Neurology, Neuroscience +10

1–5 of 10